Thrivent Financial for Lutherans
COLL icon

Thrivent Financial for Lutherans’s Collegium Pharmaceutical COLL Stock Holding History

Thrivent Financial for Lutherans’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$771K Buy
21,298
+198
+0.9% +$6.77K ﹤0.01% 2123
2026
Q1 		$698K Sell
21,100
-622
-3% -$26.3K ﹤0.01% 2078
2025
Q4 		$1.01M Sell
21,722
-1,005
-4% -$42K ﹤0.01% 1930
2025
Q3 		$795K Sell
22,727
-908
-4% -$31.6K ﹤0.01% 1901
2025
Q2 		$699K Sell
23,635
-53
-0.2% -$1.51K ﹤0.01% 1986
2025
Q1 		$707K Sell
23,688
-1,240
-5% -$37.9K ﹤0.01% 1921
2024
Q4 		$714K Sell
24,928
-369
-1% -$12.2K ﹤0.01% 2081
2024
Q3 		$977K Sell
25,297
-1,861
-7% -$66.4K ﹤0.01% 1930
2024
Q2 		$874K Sell
27,158
-1,133
-4% -$39.3K ﹤0.01% 1933
2024
Q1 		$1.1M Sell
28,291
-768
-3% -$26.9K ﹤0.01% 1857
2023
Q4 		$894K Sell
29,059
-2,716
-9% -$68K ﹤0.01% 1910
2023
Q3 		$710K Sell
31,775
-1,320
-4% -$30.1K ﹤0.01% 1949
2023
Q2 		$711K Sell
33,095
-175
-0.5% -$3.97K ﹤0.01% 2016
2023
Q1 		$798K Sell
33,270
-1,166
-3% -$30.9K ﹤0.01% 1916
2022
Q4 		$799K Sell
34,436
-841
-2% -$17K ﹤0.01% 1878
2022
Q3 		$565K Buy
35,277
+1,900
+6% +$33.5K ﹤0.01% 2018
2022
Q2 		$591K Buy
33,377
+5,235
+19% +$88.1K ﹤0.01% 2017
2022
Q1 		$573K Buy
28,142
+9
+0% +$170 ﹤0.01% 2130
2021
Q4 		$526K Sell
28,133
-614
-2% -$12K ﹤0.01% 2175
2021
Q3 		$567K Sell
28,747
-68
-0.2% -$1.47K ﹤0.01% 2134
2021
Q2 		$681K Buy
28,815
+264
+0.9% +$6.1K ﹤0.01% 2066
2021
Q1 		$677K Buy
+28,551
New +$678K ﹤0.01% 2090

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Thrivent Financial for Lutherans's COLL Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its Collegium Pharmaceutical (COLL) stake by 0.94% in Q2 2026, buying an estimated $6.77K and bringing the position to 21,298 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Thrivent Financial for Lutherans first reported a position in COLL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.1M in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Thrivent Financial for Lutherans held 21,298 shares of Collegium Pharmaceutical worth $771K as of Q2 2026.
  • Thrivent Financial for Lutherans bought 198 Collegium Pharmaceutical shares in Q2 2026, an estimated $6.77K.
  • Collegium Pharmaceutical made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2123 holding.
  • Thrivent Financial for Lutherans first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • Thrivent Financial for Lutherans's Collegium Pharmaceutical position peaked at $1.1M in Q1 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.